A clear introduction to biotech as an investable asset class, grounded in both real-world impact and financial opportunity. You’ll understand how innovation moves from lab to market and where investors...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A practical look at where angel investors play across the biotech lifecycle, from early proof-of-concept to value inflection points. Learn how capital, timing, and strategic support influence outcomes in a...

A breakdown of how drugs move from discovery to commercialization, including clinical development, manufacturing, and exit pathways. You’ll see where value is created, where risk accumulates, and what it takes...

An examination of how medical devices are developed, regulated, and brought to market. The session highlights how clinical impact, usability, reimbursement, and cost structure influence adoption, scalability, and investor returns.

A look at how diagnostics and BioTools companies create value by enabling faster, more accurate insights across clinical care and research. Key drivers include biomarker relevance, throughput, regulatory pathways, and...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

An exploration of how software and data-driven solutions are reshaping healthcare delivery, research, and operations. The session distinguishes digital health, health tech, and tech bio, while highlighting how integration, user...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.